Angiopoietin-like proteins 3, 4 and 8: regulating lipid metabolism and providing new hope for metabolic syndrome

References

• Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci 1999;892:146–54
   PubMed Web of Science ®Google Scholar
• Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell 2001;104:531–43
   PubMed Web of Science ®Google Scholar
• Billington CJ, Epstein LH, Goodwin NJ, et al. Overweight, obesity, and health risk. Arch Intern Med 2000;160:898–904
   PubMed Web of Science ®Google Scholar
• Hu G, Qiao Q, Tuomilehto J. The metabolic syndrome and cardiovascular risk. Curr Diabetes Rev 2005;1:137–43
   PubMedGoogle Scholar
• Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999;83:25F–9F
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735–52
   PubMed Web of Science ®Google Scholar
• Oike Y, Akao M, Kubota Y, Suda T. Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy. Trends Mol Med 2005;11:473–9
   PubMed Web of Science ®Google Scholar
• Camenisch G, Pisabarro MT, Sherman D, et al. ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo. J Biol Chem 2002;277:17281–90
   PubMed Web of Science ®Google Scholar
• Zhang CC, Kaba M, Ge G, et al. Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat Med 2006;12:240–5
   PubMed Web of Science ®Google Scholar
• Mattijssen F, Kersten S. Regulation of triglyceride metabolism by angiopoietin-like proteins. Biochim Biophys Acta 2012;1821:782–9
   PubMed Web of Science ®Google Scholar
• Kersten S. Regulation of lipid metabolism via angiopoietin-like proteins. Biochem Soc Trans 2005;33:1059–62
   PubMed Web of Science ®Google Scholar
• Galaup A, Cazes A, Le Jan S, et al. Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci USA 2006;103:18721–6
   PubMed Web of Science ®Google Scholar
• Hato T, Tabata M, Oike Y. The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc Med 2008;18:6–14
   PubMed Web of Science ®Google Scholar
• Tabata M, Kadomatsu T, Fukuhara S, et al. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab 2009;10:178–88
   PubMed Web of Science ®Google Scholar
• Zhu P, Goh YY, Chin HF, et al. Angiopoietin-like 4: a decade of research. Biosci Rep 2012;32:211–19
   PubMed Web of Science ®Google Scholar
• Kim I, Moon SO, Koh KN, et al. Molecular cloning, expression, and characterization of angiopoietin-related protein. Angiopoietin-related protein induces endothelial cell sprouting. J Biol Chem 1999;274:26523–8
   PubMed Web of Science ®Google Scholar
• Kim I, Kim HG, Kim H, et al. Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem J 2000;346:603–10
   PubMed Web of Science ®Google Scholar
• Dhanabal M, Jeffers M, LaRochelle WJ, Lichenstein HS. Angioarrestin: a unique angiopoietin-related protein with anti-angiogenic properties. Biochem Biophys Res Commun 2005;333:308–15
   PubMed Web of Science ®Google Scholar
• Smagur A, Szary J, Szala S. Recombinant angioarrestin secreted from mouse melanoma cells inhibits growth of primary tumours. Acta Biochim Pol 2005;52:875–9
   PubMed Web of Science ®Google Scholar
• Kuo TC, Tan CT, Chang YW, et al. Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility. J Clin Invest 2013;123:1082–95
   PubMed Web of Science ®Google Scholar
• Aoi J, Endo M, Kadomatsu T, et al. Angiopoietin-like protein 2 is an important facilitator of inflammatory carcinogenesis and metastasis. Cancer Res 2011;71:7502–12
   PubMed Web of Science ®Google Scholar
• Tan MJ, Teo Z, Sng MK, et al. Emerging roles of angiopoietin-like 4 in human cancer. Mol Cancer Res 2012;10:677–88
   PubMed Web of Science ®Google Scholar
• Romeo S, Yin W, Kozlitina J, et al. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J Clin Invest 2009;119:70–9
   PubMed Web of Science ®Google Scholar
• Comes N, Buie LK, Borrás T. Evidence for a role of angiopoietin-like7 (ANGPTL7) in extracellular matrix formation of the human trabecular meshwork: implications for glaucoma. Genes Cells 2011;16:243–59
   PubMed Web of Science ®Google Scholar
• Fu Z, Yao F, Abou-Samra AB, Zhang R. Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family. Biochem Biophys Res Commun, 2013;430:1126–31
   PubMed Web of Science ®Google Scholar
• Zhang R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun 2012;424:786–92
   PubMed Web of Science ®Google Scholar
• Quagliarini F, Wang Y, Kozlitina J, et al. Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci USA 2012;109:19751–6
   PubMed Web of Science ®Google Scholar
• Wang Y, Quagliarini F, Gusarova V, et al. Mice lacking ANGPTL8 (betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci USA 2013;110:16109–14
   PubMed Web of Science ®Google Scholar
• Lee EC, Desai U, Gololobov G, et al. Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL). J Biol Chem 2009;284:13735–45
   PubMed Web of Science ®Google Scholar
• Koishi R, Ando Y, Ono M, et al. ANGPTL3 regulates lipid metabolism in mice. Nat Genet 2002;30:151–7
   PubMed Web of Science ®Google Scholar
• Ono M, Shimizugawa T, Shimamura M, et al. Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo. J Biol Chem 2003;278:41804–9
   PubMed Web of Science ®Google Scholar
• Köster A, Chao YB, Mosior M, et al. Transgenic angiopoietin-like (ANGPTL)4 overexpression and targeted disruption of ANGPTL4 and ANGPTL3: regulation of triglyceride metabolism. Endocrinology 2005;146:4943–50
   PubMed Web of Science ®Google Scholar
• Blasius AL, Brandl K, Crozat K, et al. Mice with mutations of Dock7 have generalized hypopigmentation and white-spotting but show normal neurological function. Proc Natl Acad Sci USA 2009;106:2706–11
   PubMed Web of Science ®Google Scholar
• Shaheen R, Faqeih E, Sunker A, et al. Recessive mutations in DOCK6, encoding the guanidine nucleotide exchange factor DOCK6, lead to abnormal actin cytoskeleton organization and Adams-Oliver syndrome. Am J Hum Genet 2011;89:328–33
   PubMed Web of Science ®Google Scholar
• Zhang R, Abou-Samra AB. Emerging roles of lipasin as a critical lipid regulator. Biochem Biophys Res Commun 2013;432:401–5
   PubMed Web of Science ®Google Scholar
• Yi P, Park JS, Melton DA. Betatrophin: a hormone that controls pancreatic β cell proliferation. Cell 2013;153:747–58
   PubMed Web of Science ®Google Scholar
• Ren G, Kim JY, Smas CM. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab 2012;303:E334–51
   PubMed Web of Science ®Google Scholar
• Pelham HR. The retention signal for soluble proteins of the endoplasmic reticulum. Trends Biochem Sci 1990;15:483–6
   PubMed Web of Science ®Google Scholar
• Romeo S, Pennacchio LA, Fu Y, et al. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet 2007;39:513–16
   PubMed Web of Science ®Google Scholar
• Musunuru K, Pirruccello JP, Do R, et al. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N Engl J Med 2010;363:2220–7
   PubMed Web of Science ®Google Scholar
• Desai U, Lee EC, Chung K, et al. Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice. Proc Natl Acad Sci USA 2007;104:11766–71
   PubMed Web of Science ®Google Scholar
• Ge H, Cha JY, Gopal H, et al. Differential regulation and properties of angiopoietin-like proteins3 and 4. J Lipid Res 2005;46:1484–90
   PubMed Web of Science ®Google Scholar
• Fujimoto K, Koishi R, Shimizugawa T, Ando Y. Angptl3-null mice show low plasma lipid concentrations by enhanced lipoprotein lipase activity. Exp Anim 2006;55:27–34
   PubMed Web of Science ®Google Scholar
• Shan L, Yu XC, Liu Z, et al. The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms. J Biol Chem 2009;284:1419–24
   PubMed Web of Science ®Google Scholar
• Yin W, Romeo S, Chang S, et al. Genetic variation in ANGPTL4 provides insights into protein processing and function. J Biol Chem 2009;284:13213–22
   PubMed Web of Science ®Google Scholar
• Jin W, Wang X, Millar JS, et al. Hepatic proprotein convertases modulate HDL metabolism. Cell Metab 2007;6:129–36
   PubMed Web of Science ®Google Scholar
• Schjoldager KT, Vester-Christensen MB, Bennett EP, et al. O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: possible role of polypeptide GalNActransferase-2 in regulation of concentrations of plasma lipids. J Biol Chem 2010;285:36293–303
   PubMed Web of Science ®Google Scholar
• Inaba T, Matsuda M, Shimamura M, et al. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor. J Biol Chem 2003;278:21344–51
   PubMed Web of Science ®Google Scholar
• Kaplan R, Zhang T, Hernandez M, et al. Regulation of the angiopoietin-like protein 3 gene by LXR. J Lipid Res 2003;44:136–43
   PubMed Web of Science ®Google Scholar
• Matsusue K, Miyoshi A, Yamano S, Gonzalez FJ. Ligand-activated PPARbeta efficiently represses the induction of LXR-dependent promoter activity through competition with RXR. Mol Cell Endocrinol 2006;256:23–33
   PubMed Web of Science ®Google Scholar
• Inukai K, Nakashima Y, Watanabe M, et al. ANGPTL3 is increased in both insulin-deficient and -resistant diabetic states. Biochem Biophys Res Commun 2004;317:1075–9
   PubMed Web of Science ®Google Scholar
• Shimamura M, Matsuda M, Ando Y, et al. Leptin and insulin down-regulate angiopoietin-like protein 3, a plasma triglyceride-increasing factor. Biochem Biophys Res Commun 2004;322:1080–5
   PubMed Web of Science ®Google Scholar
• Fugier C, Tousaint JJ, Prieur X, et al. The lipoprotein lipase inhibitor ANGPTL3 is negatively regulated by thyroid hormone. J Biol Chem 2006;281:11553–9
   PubMed Web of Science ®Google Scholar
• Lu B, Moser A, Shigenaga JK, et al. The acute phase response stimulates the expression of angiopoietin like protein 4. Biochem Biophys Res Commun 2010;391:1737–41
   PubMed Web of Science ®Google Scholar
• Lei X, Shi F, Basu D, et al. Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity. J Biol Chem 2011;286:15747–56
   PubMed Web of Science ®Google Scholar
• Ge H, Yang G, Yu X, et al. Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4. J Lipid Res 2004;45:2071–9
   PubMed Web of Science ®Google Scholar
• Mandard S, Zandbergen F, Tan NS, et al. The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J Biol Chem 2004;279:34411–20
   PubMed Web of Science ®Google Scholar
• Heinäniemi M, Uski JO, Degenhardt T, Carlberg C. Meta-analysis of primary target genes of peroxisome proliferator-activated receptors. Genome Biol 2007;8:R147
   PubMedGoogle Scholar
• Kaddatz K, Adhikary T, Finkernagel F, et al. Transcriptional profiling identifies functional interactions of TGF β and PPAR β/δ signaling: synergistic induction of ANGPTL4 transcription. J Biol Chem 2010;285:29469–79
   PubMed Web of Science ®Google Scholar
• Stockert J, Adhikary T, Kaddatz K, et al. Reverse crosstalk of TGFβ and PPARβ/δ signaling identified by transcriptional profiling. Nucleic Acids Res 2011;39:119–31
   PubMed Web of Science ®Google Scholar
• Yamada T, Ozaki N, Kato Y, et al. Insulin downregulates angiopoietin-like protein 4 mRNA in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2006;347:1138–44
   PubMed Web of Science ®Google Scholar
• Koliwad SK, Kuo T, Shipp LE, et al. Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism. J Biol Chem 2009;284:25593–601
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 2008;77:289–312
   PubMed Web of Science ®Google Scholar
• Siersbaek R, Nielsen R, Mandrup S. PPARgamma in adipocyte differentiation and metabolism – novel insights from genome-wide studies. FEBS Lett 2010;584:3242–9
   PubMed Web of Science ®Google Scholar
• McGarry JD. Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002;51:7–18
   PubMed Web of Science ®Google Scholar
• Unger RH. Lopotoxic disease. Annu Rev Med 2002;53:319–36
   PubMed Web of Science ®Google Scholar
• Xu A, Lam MC, Chan KW, et al. Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc Natl Acad Sci USA 2005;102:6086–91
   PubMed Web of Science ®Google Scholar
• Wang Y, Lam KS, Lam JB, et al. Overexpression of angiopoietin-like protein 4 alters mitochondria activities and modulates methionine metabolic cycle in the liver tissues of db/db diabetic mice. Mol Endocrinol 2007;21:972–86
   PubMed Web of Science ®Google Scholar
• Jonker JT, Smit JW, Hammer S, et al. Dietary modulation of plasma angiopoietin-like protein 4 concentrations in healthy volunteers and in patients with type 2 diabetes. Am J Clin Nutr 2013;97:255–60
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li R, Meng Y, et al. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes 2014;63:514–25
   PubMed Web of Science ®Google Scholar